Login / Signup

Bcl-2 and Noxa are potential prognostic indicators for patients with gastroenteropancreatic neuroendocrine neoplasms.

Yu GuoLin ZhangNing ZhangLuohai ChenQiuyun LuoMan LiuDajun YangJie Chen
Published in: Endocrine (2022)
Higher expression of Bcl-2 and lower expression of Noxa were associated with unfavorable prognosis of GEP-NENs patients.
Keyphrases
  • poor prognosis
  • end stage renal disease
  • chronic kidney disease
  • newly diagnosed
  • binding protein
  • prognostic factors
  • peritoneal dialysis
  • long non coding rna
  • patient reported outcomes
  • patient reported